Effective influenza management has presented a challenge to medical science because the flu virus constantly changes.
Surface structures on the virus vary from year to year, requiring revisions to the annual vaccine and requiring an extensive surveillance network to collect specimens and gather information about the virus.
Although the vaccine is highly effective, some people do not respond well and are not fully protected.
Current treatments are available for influenza including neuraminidase inhibitors. It's important to see your physician at the first sign of flu.
Neuraminidase inhibitors target the neuraminidase molecule, which is responsible for the release of newly formed viral particles from the cells infected with the influenza virus.
Copyright 2008, FluSTAR.com
FluSTAR is a registered trademark of Hoffmann-La Roche Laboratories Inc.